Psyence Biomedical Ltd. Warrant – NASDAQ:PBMWW
Psyence Biomedical Ltd. Warrant stock price today
Psyence Biomedical Ltd. Warrant stock price monthly change
Psyence Biomedical Ltd. Warrant stock price quarterly change
Psyence Biomedical Ltd. Warrant key metrics
Market Cap | 346.59K |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePsyence Biomedical Ltd. Warrant stock price history
Psyence Biomedical Ltd. Warrant stock forecast
Psyence Biomedical Ltd. Warrant financial statements
| 2024 | 0 | -51.15M |
|---|
| 2024 | 1132159 | 12.10M | 1069.17% |
|---|
| 2023 | -1.59M | 0 | 1.17M |
|---|---|---|---|
| 2024 | -2.94M | -5.72K | 2.35M |
Psyence Biomedical Ltd. Warrant other data
-
What's the price of Psyence Biomedical Ltd. Warrant stock today?
One share of Psyence Biomedical Ltd. Warrant stock can currently be purchased for approximately $0.03.
-
When is Psyence Biomedical Ltd. Warrant's next earnings date?
Unfortunately, Psyence Biomedical Ltd. Warrant's (PBMWW) next earnings date is currently unknown.
-
Does Psyence Biomedical Ltd. Warrant pay dividends?
No, Psyence Biomedical Ltd. Warrant does not pay dividends.
-
How much money does Psyence Biomedical Ltd. Warrant make?
Psyence Biomedical Ltd. Warrant has a market capitalization of 346.59K.
-
What is Psyence Biomedical Ltd. Warrant's stock symbol?
Psyence Biomedical Ltd. Warrant is traded on the NASDAQ under the ticker symbol "PBMWW".
-
How do i buy shares of Psyence Biomedical Ltd. Warrant?
Shares of Psyence Biomedical Ltd. Warrant can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.